NCT02723539View on ClinicalTrials.gov

A Trial to Assess Safety and Efficacy of Topical MBN-101 in Patients With Moderate/ Severe DFI

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

March 6, 2017

Primary Completion Date

November 1, 2017

Study Completion Date

July 26, 2019

Conditions
Diabetic Foot Infection
Interventions
DRUG

MBN-101

Topical application

DRUG

Placebo

Topical application

Trial Locations (2)

78501

Futuro Clinical Trials, LLC, McAllen

93710

Limb Preservation Platform, Inc, Fresno

Sponsors
All Listed Sponsors
lead

Microbion Corporation

INDUSTRY